CLINICAL_TRIALS
research
· 2026-03-09
Clinical Trial Update: Trial of JYB1904 Injection in Patients With Perennial Allergic Rhinitis [Phase 2]
Summary
A Phase 2 clinical trial evaluating JYB1904 Injection for perennial allergic rhinitis is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jemincare | Conditions: Perennial Allergic Rhinitis | Phase 2 | Status: NOT_YET_RECRUITING